The CIS insulin market was valued at USD 3.05 billion in 2023 and is anticipated to reach USD 4.67 billion by 2030, growing at a CAGR of 5.6% from 2024 to 2030. The market growth is primarily driven by the rising prevalence of diabetes, lifestyle changes leading to obesity, and the growing awareness regarding effective diabetes management. Increasing investments in research and development,...